Group announced the completion of a new license and manufacturing agreement with Smoker Friendly. The agreement includes 11 ...
Here's everything you need to know about Dell's new business laptop lineup, and the PC maker's big 2025 rebranding effort.
The 5 most common deathbed regrets, according to a palliative care nurse ...
The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who are 10 years old and up with Type 2 diabetes. The liraglutide ...
The approval is for the generic versions of Victoza to treat Type-2 Diabetes and Saxenda used in the treatment of weight management It can be used for medicines that do not need to be authorised via ...
The approval is for the generic versions of Victoza to treat Type-2 Diabetes and Saxenda used in the treatment of weight management, Biocon Ltd said in a regulatory filing. Also read: Has ...
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...
The American Express Business Checking account checks a lot of boxes, with no monthly or incidental fees and a competitive APY. Its only major drawback is not supporting cash deposits. Smart money ...
Global pharma major Lupin Limited on Wednesday announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA ...
Flooss, the leading provider of digital financial solutions in Bahrain, has announced an agreement with Bahrain Channels to offer Islamic Shariah-approved financing solutions. The agreement was signed ...
Live Oak’s online business checking account lacks the bells and whistles of its competitors, but the bank’s high-yield business savings account shines with a high APY and no minimum balance ...
Granules India has received U.S. Food and Drug Administration approval for Lisdexamfetamine Dimesylate chewable tablets, its generic version of Takeda Pharmaceuticals’ central nervous system ...